Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Activity of imipenem/relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic β-lactam resistant mutants.

Fraile-Ribot P, Zamorano L, Orellana R, Barrio-Tofiño ED, Sánchez-Diener I, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas study Group.

Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02165-19. doi: 10.1128/AAC.02165-19. [Epub ahead of print]

PMID:
31740559
2.

Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.

Del Barrio-Tofiño E, Sánchez-Diener I, Zamorano L, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI .

J Antimicrob Chemother. 2019 Nov 1;74(11):3217-3220. doi: 10.1093/jac/dkz346.

PMID:
31430372
3.

In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting Immunity.

Torrens G, Sánchez-Diener I, Jordana-Lluch E, Barceló IM, Zamorano L, Juan C, Oliver A.

J Infect Dis. 2019 Oct 22;220(11):1729-1737. doi: 10.1093/infdis/jiz377.

PMID:
31325363
4.

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Rodriguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A.

Clin Microbiol Infect. 2019 Jul 6. pii: S1198-743X(19)30389-1. doi: 10.1016/j.cmi.2019.06.034. [Epub ahead of print]

PMID:
31288102
5.

Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.

Del Barrio-Tofiño E, Zamorano L, Cortes-Lara S, López-Causapé C, Sánchez-Diener I, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas study Group .

J Antimicrob Chemother. 2019 Jul 1;74(7):1825-1835. doi: 10.1093/jac/dkz147.

PMID:
30989186
6.

Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa.

Cabot G, Florit-Mendoza L, Sánchez-Diener I, Zamorano L, Oliver A.

J Antimicrob Chemother. 2018 Dec 1;73(12):3322-3331. doi: 10.1093/jac/dky364.

PMID:
30189050
7.

Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model.

Montero M, VanScoy BD, López-Causapé C, Conde H, Adams J, Segura C, Zamorano L, Oliver A, Horcajada JP, Ambrose PG.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00026-18. doi: 10.1128/AAC.00026-18. Print 2018 May.

8.

Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02352-17. doi: 10.1128/AAC.02352-17. Print 2018 Jan. No abstract available.

9.

Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.

Sánchez-Diener I, Zamorano L, López-Causapé C, Cabot G, Mulet X, Peña C, Del Campo R, Cantón R, Doménech-Sánchez A, Martínez-Martínez L, Arcos SC, Navas A, Oliver A.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01586-17. doi: 10.1128/AAC.01586-17. Print 2017 Dec.

10.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01589-17. doi: 10.1128/AAC.01589-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

11.

Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system.

Torrens G, Pérez-Gallego M, Moya B, Munar-Bestard M, Zamorano L, Cabot G, Blázquez J, Ayala JA, Oliver A, Juan C.

PLoS One. 2017 Jul 25;12(7):e0181932. doi: 10.1371/journal.pone.0181932. eCollection 2017.

12.

Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop.

Pérez-Llarena FJ, Vázquez-Ucha JC, Kerff F, Zamorano L, Miró E, Cabral MP, Fleites A, Lantero M, Martínez-Martínez L, Oliver A, Galleni M, Navarro F, Beceiro A, Bou G.

Microb Drug Resist. 2018 Jun;24(5):527-533. doi: 10.1089/mdr.2017.0017. Epub 2017 Jun 30.

PMID:
28665771
13.

Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.

Tam VH, Chang KT, Zhou J, Ledesma KR, Phe K, Gao S, Van Bambeke F, Sánchez-Díaz AM, Zamorano L, Oliver A, Cantón R.

J Antimicrob Chemother. 2017 May 1;72(5):1421-1428. doi: 10.1093/jac/dkx001.

PMID:
28158470
14.

Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.

Hamou-Segarra M, Zamorano L, Vadlamani G, Chu M, Sanchez-Diener I, Juan C, Blazquez J, Hattie M, Stubbs KA, Mark BL, Oliver A.

J Antimicrob Chemother. 2017 Feb;72(2):448-454. doi: 10.1093/jac/dkw456. Epub 2016 Dec 20.

PMID:
27999022
15.

Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.

López-Hernández I, Alonso N, Fernández-Martínez M, Zamorano L, Rivera A, Oliver A, Conejo MC, Martínez-Martínez L, Navarro F, Pascual A.

Enferm Infecc Microbiol Clin. 2017 Oct;35(8):499-504. doi: 10.1016/j.eimc.2016.09.013. Epub 2016 Nov 22. English, Spanish.

PMID:
27887765
16.

Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?

Pérez-Gallego M, Torrens G, Castillo-Vera J, Moya B, Zamorano L, Cabot G, Hultenby K, Albertí S, Mellroth P, Henriques-Normark B, Normark S, Oliver A, Juan C.

MBio. 2016 Oct 25;7(5). pii: e01783-16. doi: 10.1128/mBio.01783-16.

17.

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Plesiat P, Oliver A.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7415-7423. Print 2016 Dec.

18.

Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms.

Torrens G, Cabot G, Ocampo-Sosa AA, Conejo MC, Zamorano L, Navarro F, Pascual Á, Martínez-Martínez L, Oliver A.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6407-10. doi: 10.1128/AAC.01282-16. Print 2016 Oct.

19.

VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain.

Zamorano L, Mulet X, Garau M, Gallegos C, Juan C, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3251-2. doi: 10.1128/AAC.03081-15. Print 2016 May. No abstract available.

20.

Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Cabot G, Zamorano L, Moyà B, Juan C, Navas A, Blázquez J, Oliver A.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1767-78. doi: 10.1128/AAC.02676-15.

21.

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

Mikucionyte G, Zamorano L, Vitkauskiene A, López-Causapé C, Juan C, Mulet X, Oliver A.

Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):195-200. doi: 10.1007/s10096-015-2529-0. Epub 2015 Dec 5.

PMID:
26638216
22.

Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.

Palacios-Baena ZR, Oteo J, Conejo C, Larrosa MN, Bou G, Fernández-Martínez M, González-López JJ, Pintado V, Martínez-Martínez L, Merino M, Pomar V, Mora-Rillo M, Rivera MA, Oliver A, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Zamorano L, Bautista V, Ortega A, Morales I, Pascual Á, Campos J, Rodríguez-Baño J; GEIH-GEMARA (SEIMC) and REIPI Group for CPE.

J Infect. 2016 Feb;72(2):152-60. doi: 10.1016/j.jinf.2015.10.008. Epub 2015 Nov 4.

PMID:
26546855
23.

In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.

Solé M, Fàbrega A, Cobos-Trigueros N, Zamorano L, Ferrer-Navarro M, Ballesté-Delpierre C, Reustle A, Castro P, Nicolás JM, Oliver A, Martínez JA, Vila J.

J Antimicrob Chemother. 2015 Nov;70(11):3004-13. doi: 10.1093/jac/dkv228. Epub 2015 Aug 9.

PMID:
26260130
24.

Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain.

Oteo J, Alcaraz R, Bou G, Conejo C, Díaz-Lamas AM, Fernández-Martínez M, Fontanals D, González-López JJ, López-Contreras J, Martínez-Martínez L, Mora-Rillo M, Muñoz M, Navarro F, Oliver A, Pintado V, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Sánchez-Porto A, Sánchez-Romero I, Zamorano L, Aracil B, Rodríguez-Baño J; Spanish Network for Research in Infectious Diseases (REIPI); GEIH-GEMARA (SEIMC).

J Antimicrob Chemother. 2015 Oct;70(10):2916-8. doi: 10.1093/jac/dkv187. Epub 2015 Jul 9. No abstract available.

PMID:
26163400
25.

Mobile genetic elements related to the diffusion of plasmid-mediated AmpC β-lactamases or carbapenemases from Enterobacteriaceae: findings from a multicenter study in Spain.

Zamorano L, Miró E, Juan C, Gómez L, Bou G, González-López JJ, Martínez-Martínez L, Aracil B, Conejo MC, Oliver A, Navarro F.

Antimicrob Agents Chemother. 2015 Sep;59(9):5260-6. doi: 10.1128/AAC.00562-15. Epub 2015 Jun 15.

26.

Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Oteo J, Ortega A, Bartolomé R, Bou G, Conejo C, Fernández-Martínez M, González-López JJ, Martínez-García L, Martínez-Martínez L, Merino M, Miró E, Mora M, Navarro F, Oliver A, Pascual Á, Rodríguez-Baño J, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Zamorano L, Bautista V, Pérez-Vázquez M, Campos J; GEIH-GEMARA (SEIMC) and REIPI.

Antimicrob Agents Chemother. 2015;59(6):3406-12. doi: 10.1128/AAC.00086-15. Epub 2015 Mar 30.

27.

Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.

Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2015 Feb 15;60(4):539-48. doi: 10.1093/cid/ciu866. Epub 2014 Nov 6.

PMID:
25378459
28.
29.

Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7.

Pérez-Llarena FJ, Zamorano L, Kerff F, Beceiro A, García P, Miró E, Larrosa N, Gómez-Bertomeu F, Méndez JA, González-López JJ, Oliver A, Galleni M, Navarro F, Bou G.

Antimicrob Agents Chemother. 2014 Nov;58(11):6544-9. doi: 10.1128/AAC.03144-14. Epub 2014 Aug 18.

30.

The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.

Zamorano L, Moyà B, Juan C, Mulet X, Blázquez J, Oliver A.

Antimicrob Agents Chemother. 2014 Sep;58(9):5084-95. doi: 10.1128/AAC.02556-14. Epub 2014 Jun 16.

31.

Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.

Cabot G, Bruchmann S, Mulet X, Zamorano L, Moyà B, Juan C, Haussler S, Oliver A.

Antimicrob Agents Chemother. 2014 Jun;58(6):3091-9. doi: 10.1128/AAC.02462-13. Epub 2014 Mar 17.

32.

Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.

Mulet X, Cabot G, Ocampo-Sosa AA, Domínguez MA, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Antimicrob Agents Chemother. 2013 Nov;57(11):5527-35. doi: 10.1128/AAC.01481-13. Epub 2013 Aug 26.

33.

Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis.

Pérez-Llarena FJ, Kerff F, Zamorano L, Fernández MC, Nuñez ML, Miró E, Oliver A, Navarro F, Bou G.

Antimicrob Agents Chemother. 2013 Oct;57(10):5158-61. doi: 10.1128/AAC.00818-13. Epub 2013 Jul 22.

34.

Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.

Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.

Microb Drug Resist. 2013 Oct;19(5):355-61. doi: 10.1089/mdr.2013.0004. Epub 2013 Apr 21.

PMID:
23600605
35.

Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, González-López JJ, Lara N, Martínez-Martínez L, Oliver A, Aracil B, Oteo J, Pascual A, Rodríguez-Baño J, Zamorano L, Navarro F.

Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):253-9. doi: 10.1007/s10096-012-1737-0. Epub 2012 Sep 7. Erratum in: Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):261-2.

PMID:
22956023
36.

Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.

Moyá B, Beceiro A, Cabot G, Juan C, Zamorano L, Alberti S, Oliver A.

Antimicrob Agents Chemother. 2012 Sep;56(9):4771-8. doi: 10.1128/AAC.00680-12. Epub 2012 Jun 25.

37.

Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.

Pérez-Llarena FJ, Fernández A, Zamorano L, Kerff F, Beceiro A, Aracil B, Cercenado E, Miro E, Oliver A, Oteo J, Navarro F, Bou G.

Antimicrob Agents Chemother. 2012 Aug;56(8):4540-3. doi: 10.1128/AAC.00776-12. Epub 2012 Jun 5.

38.

Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.

Ocampo-Sosa AA, Cabot G, Rodríguez C, Roman E, Tubau F, Macia MD, Moya B, Zamorano L, Suárez C, Peña C, Domínguez MA, Moncalián G, Oliver A, Martínez-Martínez L; Spanish Network for Research in Infectious Diseases (REIPI).

Antimicrob Agents Chemother. 2012 Apr;56(4):1703-13. doi: 10.1128/AAC.05451-11. Epub 2012 Jan 30.

39.

Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain.

Gopegui ER, Juan C, Zamorano L, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2012 Apr;56(4):2139-42. doi: 10.1128/AAC.06042-11. Epub 2012 Jan 3.

40.

Fluid intelligence and psychosocial outcome: from logical problem solving to social adaptation.

Huepe D, Roca M, Salas N, Canales-Johnson A, Rivera-Rei ÁA, Zamorano L, Concepción A, Manes F, Ibañez A.

PLoS One. 2011;6(9):e24858. doi: 10.1371/journal.pone.0024858. Epub 2011 Sep 21.

41.

AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.

Zamorano L, Reeve TM, Juan C, Moyá B, Cabot G, Vocadlo DJ, Mark BL, Oliver A.

Antimicrob Agents Chemother. 2011 May;55(5):1990-6. doi: 10.1128/AAC.01688-10. Epub 2011 Feb 28.

42.

Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodríguez C, Moya B, Zamorano L, Suárez C, Peña C, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Antimicrob Agents Chemother. 2011 May;55(5):1906-11. doi: 10.1128/AAC.01645-10. Epub 2011 Feb 28.

43.

NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa.

Zamorano L, Reeve TM, Deng L, Juan C, Moyá B, Cabot G, Vocadlo DJ, Mark BL, Oliver A.

Antimicrob Agents Chemother. 2010 Sep;54(9):3557-63. doi: 10.1128/AAC.00385-10. Epub 2010 Jun 21.

44.

Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.

Moyá B, Zamorano L, Juan C, Ge Y, Oliver A.

Antimicrob Agents Chemother. 2010 Sep;54(9):3933-7. doi: 10.1128/AAC.00296-10. Epub 2010 Jun 14.

45.

Differential beta-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains.

Zamorano L, Moyá B, Juan C, Oliver A.

J Antimicrob Chemother. 2010 Jul;65(7):1540-2. doi: 10.1093/jac/dkq142. Epub 2010 Apr 30. No abstract available.

PMID:
20435778
46.

Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.

Moya B, Zamorano L, Juan C, Pérez JL, Ge Y, Oliver A.

Antimicrob Agents Chemother. 2010 Mar;54(3):1213-7. doi: 10.1128/AAC.01104-09. Epub 2010 Jan 19.

47.

Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.

Juan C, Zamorano L, Mena A, Albertí S, Pérez JL, Oliver A.

J Antimicrob Chemother. 2010 Mar;65(3):474-8. doi: 10.1093/jac/dkp491. Epub 2010 Jan 12.

PMID:
20071364
48.

Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.

Zamorano L, Juan C, Fernández-Olmos A, Ge Y, Cantón R, Oliver A.

Clin Microbiol Infect. 2010 Sep;16(9):1482-7. doi: 10.1111/j.1469-0691.2009.03130.x.

49.

Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.

Juan C, Zamorano L, Pérez JL, Ge Y, Oliver A; Spanish Group for the Study of Pseudomonas; Spanish Network for Research in Infectious Diseases.

Antimicrob Agents Chemother. 2010 Feb;54(2):846-51. doi: 10.1128/AAC.00834-09. Epub 2009 Nov 23.

50.

Crystal structure and statistical coupling analysis of highly glycosylated peroxidase from royal palm tree (Roystonea regia).

Watanabe L, de Moura PR, Bleicher L, Nascimento AS, Zamorano LS, Calvete JJ, Sanz L, Pérez A, Bursakov S, Roig MG, Shnyrov VL, Polikarpov I.

J Struct Biol. 2010 Feb;169(2):226-42. doi: 10.1016/j.jsb.2009.10.009. Epub 2009 Oct 23.

PMID:
19854274

Supplemental Content

Loading ...
Support Center